Primecap Management Co. CA Buys Shares of 895,350 Synopsys, Inc. $SNPS

Primecap Management Co. CA purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 895,350 shares of the semiconductor company’s stock, valued at approximately $399,389,000. Primecap Management Co. CA owned approximately 0.47% of Synopsys as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. BlackRock Inc. bought a new position in Synopsys in the 2nd quarter worth $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Synopsys during the second quarter valued at about $747,400,000. Norges Bank bought a new stake in Synopsys during the fourth quarter valued at about $730,197,000. Bank of New York Mellon Corp acquired a new stake in shares of Synopsys in the second quarter valued at about $692,074,000. Finally, State Street Corp grew its position in shares of Synopsys by 20.6% in the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock valued at $4,322,273,000 after purchasing an additional 1,493,912 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on SNPS. Wells Fargo & Company cut their price objective on Synopsys from $535.00 to $450.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 11th. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and raised their target price for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. BNP Paribas Exane lifted their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Needham & Company LLC reiterated a “buy” rating and set a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Finally, Benchmark reissued a “buy” rating on shares of Synopsys in a research report on Wednesday, August 19th. Eleven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $563.59.

Read Our Latest Stock Report on SNPS

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $408.79 on Wednesday. The firm has a market capitalization of $78.28 billion, a PE ratio of 94.63, a PEG ratio of 2.32 and a beta of 1.23. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $615.79. The business’s 50 day moving average is $417.74 and its 200-day moving average is $439.85.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue was up 41.9% on a year-over-year basis. During the same period in the prior year, the company posted $3.67 earnings per share. Sell-side analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.